Efficacy of triplet regimen antiemetic therapy for chemotherapy‐induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single‐shot palonosetron and consecutive‐day granisetron for CINV in a randomized, single‐blinded crossover study-Reference-Cited by-同舟云学术

Efficacy of triplet regimen antiemetic therapy for chemotherapy‐induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single‐shot palonosetron and consecutive‐day granisetron for CINV in a randomized, single‐blinded crossover study

Published:2014-12-23 Issue:3 Volume:4 Page:333-341
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Kimura Hiroaki¹,Yamamoto Norio¹,Shirai Toshiharu¹,Nishida Hideji¹,Hayashi Katsuhiro¹,Tanzawa Yoshikazu¹,Takeuchi Akihiko¹,Igarashi Kentaro¹,Inatani Hiroyuki¹,Shimozaki Shingo¹,Kato Takashi¹,Aoki Yu¹,Higuchi Takashi¹,Tsuchiya Hiroyuki¹

Affiliation:

1. Department of Orthopaedic Surgery Graduate School of Medical Science Kanazawa University Kanazawa Ishikawa 920‐8641 Japan

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.373

Reference13 articles.

1. Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines

2. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

3. Contribution of Dexamethasone to Control of Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis of Randomized Evidence